Stephen Pendergast/LinkedIn
Apr 22, 2026, 15:22
Stephen Pendergast: Are Universal Shelf Stable Blood Substitutes Finally Within Reach?
Stephen Pendergast, Consultant in Systems Engineering (Radar, Data Links, and Satellite Communications) and Senior Systems Engineer, shared a post on LinkedIn:
“Researchers at Japan’s Nara Medical University have engineered hemoglobin vesicles that work for blood transfusion replacements all blood types and last for years.
As clinical trials advance, parallel efforts in the U.S. and U.K. are converging on a long-elusive goal: a shelf-stable substitute for donated blood.
This could revolutionize emergency room and battlefield emergency care.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention